Pharma Already Has the Data Foundations that the Digital Product Passport Wants
Pharmaceutical manufacturers are currently not required to provide DPPs but with the support of innovation such as the GS1 programme, the provision of a DPP-equivalent is expected to become increasingly important in supporting future regulatory and market requirements.








